- Home
- UAN vs TRDA Comparison
UAN vs TRDA Comparison
Compare UAN & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAN
- TRDA
- Stock Information
- Founded
- UAN 2007
- TRDA 2016
- Country
- UAN United States
- TRDA United States
- Employees
- UAN N/A
- TRDA N/A
- Industry
- UAN Agricultural Chemicals
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- UAN Industrials
- TRDA Health Care
- Exchange
- UAN Nasdaq
- TRDA Nasdaq
- Market Cap
- UAN 710.0M
- TRDA 609.7M
- IPO Year
- UAN 2011
- TRDA 2021
- Fundamental
- Price
- UAN $72.20
- TRDA $17.85
- Analyst Decision
- UAN
- TRDA Strong Buy
- Analyst Count
- UAN 0
- TRDA 3
- Target Price
- UAN N/A
- TRDA $23.33
- AVG Volume (30 Days)
- UAN 42.4K
- TRDA 132.5K
- Earning Date
- UAN 10-28-2024
- TRDA 11-05-2024
- Dividend Yield
- UAN 9.24%
- TRDA N/A
- EPS Growth
- UAN N/A
- TRDA N/A
- EPS
- UAN 4.97
- TRDA 1.55
- Revenue
- UAN $527,388,000.00
- TRDA $215,232,000.00
- Revenue This Year
- UAN N/A
- TRDA $47.63
- Revenue Next Year
- UAN N/A
- TRDA N/A
- P/E Ratio
- UAN $14.55
- TRDA $11.51
- Revenue Growth
- UAN N/A
- TRDA 146.92
- 52 Week Low
- UAN $60.50
- TRDA $10.75
- 52 Week High
- UAN $88.94
- TRDA $20.49
- Technical
- Relative Strength Index (RSI)
- UAN 59.13
- TRDA 48.42
- Support Level
- UAN $67.44
- TRDA $19.28
- Resistance Level
- UAN $72.22
- TRDA $20.49
- Average True Range (ATR)
- UAN 2.57
- TRDA 0.92
- MACD
- UAN 0.46
- TRDA -0.01
- Stochastic Oscillator
- UAN 76.85
- TRDA 25.21
About UAN CVR Partners LP Common Units representing Limited Partner Interests
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.